The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma
dc.contributor.author | Paek, Sandra C. | en_US |
dc.contributor.author | Griffith, Kent A. | en_US |
dc.contributor.author | Johnson, Timothy M. | en_US |
dc.contributor.author | Sondak, Vernon K. | en_US |
dc.contributor.author | Wong, Sandra L. | en_US |
dc.contributor.author | Chang, Alfred E. | en_US |
dc.contributor.author | Cimmino, Vincent M. | en_US |
dc.contributor.author | Lowe, Lori | en_US |
dc.contributor.author | Bradford, Carol R. | en_US |
dc.contributor.author | Rees, Riley S. | en_US |
dc.contributor.author | Sabel, Michael S. | en_US |
dc.date.accessioned | 2007-09-20T17:52:27Z | |
dc.date.available | 2008-04-03T18:44:20Z | en_US |
dc.date.issued | 2007-01-01 | en_US |
dc.identifier.citation | Paek, Sandra C.; Griffith, Kent A.; Johnson, Timothy M.; Sondak, Vernon K.; Wong, Sandra L.; Chang, Alfred E.; Cimmino, Vincent M.; Lowe, Lori; Bradford, Carol R.; Rees, Riley S.; Sabel, Michael S. (2007). "The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma." Cancer 109(1): 100-108. <http://hdl.handle.net/2027.42/55870> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/55870 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17146784&dopt=citation | en_US |
dc.description.abstract | BACKGROUND. In addition to Breslow depth, the authors previously described how increasing mitotic rate and decreasing age predicted sentinel lymph node (SLN) metastases in patients with melanoma. The objectives of the current study were to verify those previous results and to create a prediction model for the better selection of which patients with melanoma should undergo SLN biopsy. METHODS. The authors reviewed 1130 consecutive patients with melanoma in a prospective database who underwent successful SLN biopsy. After eliminating patients aged <16 years and patients who had melanomas that measured <1 mm, 910 remaining patients were reviewed for clinical and pathologic features and positive SLN status. Univariate association of patient and tumor characteristics with positive SLN status was explored by using standard logistic regression techniques, and the best multivariate model that predicted lymph node metastases was constructed by using a backward stepwise-elimination technique. RESULTS. The characteristics that were associated significantly with lymph node metastasis were angiolymphatic invasion, the absence of regression, increasing mitotic rate, satellitosis, ulceration, increasing Breslow depth, decreasing age, and location (trunk or lower extremity compared with upper extremity or head/neck). Previously reported interactions between mitotic rate and age and between Breslow depth and age were confirmed. The best multivariate model included patient age (linear), angiolymphatic invasion, the number of mitoses (linear), the interaction between patient age and the number of mitoses, Breslow depth (linear), the interaction between patient age and Breslow depth, and primary tumor location. CONCLUSIONS. Younger age, increasing mitotic rate (especially in younger patients), increasing Breslow depth (especially in older patients), angiolymphatic invasion, and trunk or lower extremity location of the primary tumor were associated with a greater likelihood of positive SLN status. The current results support the use of factors beyond Breslow depth to determine the risk of positive SLN status in patients with cutaneous melanoma. Cancer 2007. © 2006 American Cancer Society | en_US |
dc.format.extent | 230336 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Biostatistics Core of the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan ; Department of Otolaryngology, University of Michigan Health System, Ann Arbor, Michigan ; Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Otolaryngology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan ; Fax: (734) 647-9647 ; 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0932 | en_US |
dc.contributor.affiliationother | Department of Surgery, Moffitt Cancer Center, Tampa, Florida | en_US |
dc.identifier.pmid | 17146784 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/55870/1/22382_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/cncr.22382 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.